Cytech Products

Combating the Growing Burden of Diabetes in India. India is home to over 77 million people living with diabetes, making major contributor to the global diabetes epidemic. By 2030, this number is expected to surge to 101 million. Furthermore, a stagg.....

Cardiovascular diseases (CVDs) are the leading cause of mortality in India, accounting for over 25% of all deaths. With a growing burden of heart failure, coronary artery disease, and arrhythmias, the need for innovative cardiac solutions has never b.....

High blood pressure often remains unnoticed but can lead to serious health complications if untreated.Our hypertension range focuses on reliable therapy for long-term heart and vascular protection......

Neuropathy is becoming increasingly common in India, especially due to the rising burden of diabetes, affecting millions with symptoms like numbness, tingling, and nerve pain. At Cytech Pharma, our neuropathy portfolio is designed to improve nerve h.....

Obesity is a growing epidemic in India, affecting over 30% of the population . It's a leading risk factor for chronic diseases like diabetes, cardiovascular disease, and certain types of cancer. At Cytech Pharmaceuticals, we're committed to helping i.....

Gastrointestinal (GI) disorders affect millions of Indians, with a significant impact on quality of life and healthcare systems. At Cytech Pharmaceuticals, we are dedicated to addressing the complex needs of GI patients through our comprehensive gast.....